CGON (CG Oncology) Common Stock: $0.01 Mil (As of Mar. 2026)


CGON CG Oncology Inc CGON
12 GF Score
Price $70.40
! 5 Warning Signs
View Full Analysis

What is CG Oncology Common Stock?

CG Oncology CGON -0.75% 12 Common Stock is $0.01 Mil as of Mar. 2026. GuruFocus rates CGON with a GF Score™ of 12/100. The stock has 5 warning signs investors should review.

CG Oncology's quarterly common stock stayed the same from Sep. 2025 ($0.01 Mil) to Dec. 2025 ($0.01 Mil) but then increased from Dec. 2025 ($0.01 Mil) to Mar. 2026 ($0.01 Mil).

CG Oncology's annual common stock increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.01 Mil) but then stayed the same from Dec. 2024 ($0.01 Mil) to Dec. 2025 ($0.01 Mil).

CG Oncology Common Stock Historical Data

* Premium members only.

The historical data trend for CG Oncology's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CG Oncology Common Stock Chart

CG Oncology Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
0.00 0.00 0.00 0.01 0.01

CG Oncology Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01
CGON
12GF Score
CG Oncology Inc CGON
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CG Oncology Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.01 Mil mean?
CG Oncology (CGON) has a Common Stock of $0.01 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on CG Oncology and its competitors.
Is CG Oncology's Common Stock too high?
CG Oncology's current Common Stock is $0.01 Mil. Overall, CG Oncology has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CG Oncology's Common Stock compare to COGT and SRRK?
CG Oncology's Common Stock of $0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on CG Oncology and its competitors. CG Oncology's current Common Stock is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CG Oncology stock overvalued right now?
CG Oncology (CGON) has a current Common Stock of $0.01 Mil. The current Common Stock is $0.01 Mil. CG Oncology's overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For CG Oncology (CGON), the current Common Stock is $0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CG Oncology Business Description

Address 400 Spectrum Center Drive, Suite 2040, Irvine, CA, USA, 92618
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
12GF Score

Get the complete analysis for CGON

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$70.40
Price